Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 11, 2022, Ashish Sanghrajka tendered a letter of resignation from the
Board of Directors of Scopus BioPharma Inc. (the "Company"), effective
immediately (the "Sanghrajka Letter"). A copy of the Sanghrajka Letter, which
states his reasons for resigning, is furnished herewith as Exhibit 99.1. The
Company disagrees with the assertions and characterizations set forth in the
Sanghrajka Letter.
Pursuant to the requirements of Item 5.02 of Form 8-K, the Company has provided
Mr. Sanghrajka with a copy of this Form 8-K in accordance with Item
5.02(a)(3)(i) of Form 8-K.
Item 9.01. Financial Statement and Exhibits.
(d) Exhibits
99.1 Letter from Ashish Sanghrajka dated May 11, 2022
104 Cover Page Interactive Data File (formatted in Inline XBRL and
contained in Exhibit 101)
© Edgar Online, source Glimpses